Latest news for Nutra Pharma (OTC:NPHC) Stock

Nutra Pharma Corp operates as a biotechnology company specializing in the acquisition, licensing, and commercialization of pharmaceutical products and technologies for the management of neurological disorders, cancer, autoimmune, and infectious diseases. It also develops proprietary therapeutic protein products primarily for the prevention and treatment of viral and neurological diseases, including Multiple Sclerosis (MS), Adrenomyeloneuropathy (AMN), Human Immunodeficiency Virus (HIV), and pain in humans. Some of its drug names are Cobroxin, Nyloxin, RPI-78M, RPI-MN and Pet Pain-Away.

News

Intraday Update

Markets

Movers

Trading Ideas

AAON

AAXN

ABBV

ACGL

ACIA

ACLS

ADUS

AFGC

AGRX

AGYS

AIQUY

AJRD

Allianz Ag Muenchen Namen-Akt Vinkuliert Shares

ALIZF

ALKEF

ALPMY

AMED

AMWD

AMZN

APAM

APTO

ARCC

ARES

ARKR

ARNC

ASHTF

ASHTY

ASML

ASMLF

ASND

ATRC

BFAM

Brighthouse Financial, Inc. - Common Stock

BILI

BILL

BNTGF

BPUZF

BRLXF

BTCY

BURL

BWMC

BWXT

CBRE

CCXI

CCYC

CFBK

CHCT

CHDN

CHGCY

CNRMF

CPWHF

Stocks That Hit 52-Week Highs On Tuesday

Nutra Pharma Corp

Nutra Pharma Corp. (NPHC) has shared an update. Rik J. Deitsch has stepped down from his roles as CEO, Director, Chairman of the Board, and CFO fol...

Comments

Nutra Pharma

News

Latest news for Nutra Pharma (OTC:NPHC) Stock

Tuesday, February 11, 2020

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga